In conclusion, our findings indicate that APN-mRNA-LNP effectively addresses multiple aspects of T2D pathogenesis, including glucose uptake, insulin resistance, inflammation, and diabetic complications. The gene discussed is ANPEP; the disease is type 2 diabetes mellitus.